Ambrosia Biosciences Inc. is a drug discovery company that develops orally delivered, small molecule-based therapies for obesity and other metabolic disorders.

Ambrosia Biosciences Inc.

Ambrosia Biosciences

Ambrosia Biosciences Inc. is a privately held drug discovery company developing orally delivered, small molecule-based therapies for obesity and other metabolic disorders.

💡 𝑪𝒐𝒎𝒑𝒂𝒏𝒚 𝑺𝒑𝒐𝒕𝒍𝒊𝒈𝒉𝒕 💡- Ambrosia Biosciences Inc.

❓ 𝑫𝒊𝒅 𝒚𝒐𝒖 𝒌𝒏𝒐𝒘 that they are a #drugdiscovery company developing orally delivered, small-molecule-based therapies for Obesity! 

🍾 They have just announced $16 million in Series A funding, led by Boulder Ventures & BVF PARTNERS, L.P. Based Colorado, funding will be used to scale up its drug discovery programs and laboratory operations in Boulder. 

🧑🔬 𝐀𝐦𝐛𝐫𝐨𝐬𝐢𝐚 have taken advantage of the recent shut down of a Pfizer facility, assembling the 'best-in-class' medicinal chemistry team that used to belong to Array BioPharma Inc.. 

🚀I also managed to catch up with the Founder and President, Nick Traggis who added this below 👇

🌏 Exciting times to be apart of the team. Want to learn more, give them a follow and click on the webpage -https://lnkd.in/gQt6pxWG.

#startups #lifesciences

Nick Traggis sat down with Endpoints News this week to talk about the origins of Ambrosia.

I recently spoke with Nick Traggis of Ambrosia Biosciences Inc. about their recent $16 million Series A. Read about it in my latest for the Denver Business Journal.  https://lnkd.in/gcvpbHY4

We are pleased to announce the closing of our Series A financing! Led by BVF Partners and Boulder Ventures, this funding will allow us to launch operations in Boulder, CO and fuel our exceptional drug discovery team.

COM:AMBROSIABIOSCIENCES

Ambrosia Biosciences

locale

market

industry

website

linkedin

investor of

Metrics